These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e. Susanto TA; Pua EP; Zhou J; J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955 [TBL] [Abstract][Full Text] [Related]
7. Self-reported traumatic brain injury and in vivo measure of AD-vulnerable cortical thickness and AD-related biomarkers in the ADNI cohort. Wang ML; Wei XE; Yu MM; Li PY; Li WB; Neurosci Lett; 2017 Aug; 655():115-120. PubMed ID: 28689050 [TBL] [Abstract][Full Text] [Related]
8. Preclinical cerebrospinal fluid and volumetric magnetic resonance imaging biomarkers in Swedish familial Alzheimer's disease. Thordardottir S; Ståhlbom AK; Ferreira D; Almkvist O; Westman E; Zetterberg H; Eriksdotter M; Blennow K; Graff C J Alzheimers Dis; 2015; 43(4):1393-402. PubMed ID: 25182737 [TBL] [Abstract][Full Text] [Related]
9. Proteomic correlates of cortical thickness in cognitively normal individuals with normal and abnormal cerebrospinal fluid beta-amyloid Ekblad LL; Visser PJ; Tijms BM; Neurobiol Aging; 2021 Nov; 107():42-52. PubMed ID: 34375908 [TBL] [Abstract][Full Text] [Related]
10. Imaging and cerebrospinal fluid biomarkers in early preclinical alzheimer disease. Vlassenko AG; McCue L; Jasielec MS; Su Y; Gordon BA; Xiong C; Holtzman DM; Benzinger TL; Morris JC; Fagan AM Ann Neurol; 2016 Sep; 80(3):379-87. PubMed ID: 27398953 [TBL] [Abstract][Full Text] [Related]